CDC Backs Projects Fighting Antibiotic Resistance

"Understanding the role the microbiome plays in antibiotic-resistant infections is necessary to protect the public's health," said CDC Director Dr. Tom Frieden, M.D., MPH. "We think it is key to innovative approaches to combat antibiotic resistance, protect patients, and improve antibiotic use."

The U.S. Centers for Disease Control and Prevention announced its support Oct. 6 through $14 million in funding for new approaches to fight antibiotic resistance, including research on how microorganisms naturally present in the human body (a person's microbiome) can be used to predict and prevent infections caused by drug-resistant organisms. The awards were made through CDC's Broad Agency Announcement and support activities in the CDC Antibiotic Resistance Solutions Initiative.

"Understanding the role the microbiome plays in antibiotic-resistant infections is necessary to protect the public's health," said CDC Director Dr. Tom Frieden, M.D., MPH. "We think it is key to innovative approaches to combat antibiotic resistance, protect patients, and improve antibiotic use."

Most of the projects are being conducted through universities, along with one by a commercial company and two by a nonprofit. Awardees include Brown University, Columbia University, Cornell University, Emory University, the Georgia Institute of Technology, The Joint Commission, Ohio State University, OpenBiome, Pennsylvania State University, Rutgers University, Synthetic Biologics, Inc., University of Georgia, University of California Berkley, University of California Davis, University of Cincinnati, University of Colorado, University of Maryland, University of Michigan, University of Pennsylvania, University of Virginia, University of Oregon, University of Utah, Virginia Commonwealth University, Washington University, and Yale University. Some of the awardees are conducting multiple projects, according to CDC.

The awards will fund research exploring the link between antibiotics, the microbiome, and downstream consequences of widespread antibiotic use.

Product Showcase

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Full Line of Defense Against Combustible Dust Nilfisk

    Nilfisk provides a comprehensive range of industrial vacuums meticulously crafted to adhere to NFPA 652 housekeeping standards, essential for gathering combustible dust in Class I, Group D, and Class II, Groups E, F & G environments or non-classified settings. Our pneumatic vacuums are meticulously engineered to fulfill safety criteria for deployment in hazardous surroundings. Leveraging advanced filtration technology, Nilfisk ensures the secure capture of combustible materials scattered throughout your facility, ranging from fuels, solvents, and metal dust to flour, sugar, and pharmaceutical powders. Read More

  • Safety Shower Test Cart

    The Safety Shower Test Cart speeds up and simplifies emergency shower tests, ensures you stay in compliance with OSHA regulations, and significantly reduces testing costs. With 7 unique features, the cart makes testing easy, effective, and efficient. You can test water clarity, flow, temperature, and spread—all at the same time! Most safety shower testing kits create a mess, take too much time to use, and don't fully help you stay in compliance with OSHA & ANSI standards. Transform the way you test emergency showers with Green Gobbler Safety. Read More

Featured

Artificial Intelligence